No black box warning on record for Cytarabine

As of the latest FDA labeling reviewed, Cytarabine (CYTARABINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cytarabine medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS ( See boxed WARNING ) Cytarabine is a potent bone marrow suppressant. Therapy should be started cautiously in patients with pre-existing drug-induced bone marrow suppression. Patients receiving this drug must be under close medical supervision and, during induction therapy, should have leucocyte and platelet counts performed daily. Bone marrow examinations should be performed frequently a

No black box warning on record for Cytarabine

Other warnings & precautions

WARNINGS ( See boxed WARNING ) Cytarabine is a potent bone marrow suppressant. Therapy should be started cautiously in patients with pre-existing drug-induced bone marrow suppression. Patients receiving this drug must be under close medical supervision and, during induction therapy, should have leucocyte and platelet counts performed daily. Bone marrow examinations should be performed frequently a

Cytarabine Black Box Warning

No black box warning on record for Cytarabine

Other warnings & precautions

Cytarabine Black Box Warning

No black box warning on record for Cytarabine

Other warnings & precautions